Taken together, these findings indicate the differential potential of specific interleukins as biomarkers for the early detection of psychosis, with IL-2 and IL-1β most consistently meeting the criteria for state markers, while IL-10 may reflect a more complex immune response involving both proactive and reactive mechanisms during the acute phase of the illness. Here, IL1B is linked to psychotic disorder.